<DOC>
	<DOCNO>NCT00701519</DOCNO>
	<brief_summary>OSA associate large negative swing intrathoracic pressure , significant increase sympathetic nerve activity repetitive surge blood pressure , along episodic hypoxia hypercapnea ( 8,9 ) . These autonomic respiratory change may increase cardiac muscle workload , cardiac dysrrhythmia , exacerbate ischemia ( 10,11,12 ) . Treatment CPAP successful therapeutic modality available OSA . It still clear whether establish diagnosis OSA initiate treatment CPAP still hospital carry benefit management patient acute heart failure . This study evaluate effect work treatment OSA outcome patient hospitalize acute CHF .</brief_summary>
	<brief_title>The Prevalence Sleep Disordered Breathing Hospitalized Patients With Acutely Decompensated Heart Failure Syndrome</brief_title>
	<detailed_description>Congestive heart failure affect 2.3 % population ( approximately 4,900,000 ) incidence 10 per 1,000 population age 65 ( 1 ) . The admission rate patient heart failure rise , mortality associate national annual bill , exceed $ 21 billion ( 1 ) . Obstructive Sleep Apnea ( OSA ) present 11-37 % patient heart failure ( 2,3 ) , tend increase severity heart failure less control ( 4 , 5 ) . Therefore , actual prevalence OSA patient hospitalize acute heart failure likely high . There evidence treatment OSA nasal Continuous Positive Pressure ( nCPAP ) outpatients stable heart failure improve leave ventricular ejection fraction , quality life ( 6 ) , confers reduction fatal non-fatal cardiovascular event ( 7 ) . However , evaluation role diagnosis treatment OSA patient hospitalize acute heart failure . This uncertainty true prevalence role OSA exacerbation heart failure , role treatment acute set may explain aggressive diagnostic therapeutic strategy OSA patient admit hospital acute heart failure part standard clinical practice acute care center . Given rise admission rate , mortality associate heart failure , evaluation role OSA treatment patient population highly significant . The significance question reside mainly best approach diagnosis treatment SDB high risk vulnerable population . Should every patient wit heart failure undergo polysomnography diagnose highly likely underlie SDB , trigger appropriate treatment ? The cost polysomnography access sleep laboratory make almost prohibitive pursue approach . An approach combine evaluation risk factor abbreviate portable study may adequate certainly less expensive . Our OSU- Sleep Heart program establish deliver expedient diagnosis treatment SDB patient heart failure . In published literature , adequate data guide delivery Sleep service patient population . Our program aim target every heart failure patient validate questionnaire screen ambulatory sleep study . The sensitivity specificity surveillance approach need evaluate reference standard , polysomnography . Therefore protocol aim evaluate negative positive predictive value clinical program .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<criteria>OSU Heart Failure Patient Able Complete Survey Neurological Deficit No Heart failure Less 18 yr old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>CHF ,</keyword>
	<keyword>Sleep apnea ,</keyword>
	<keyword>Obstructive sleep apnea ,</keyword>
	<keyword>Heart failure</keyword>
</DOC>